Significant Tumor Response to the Poly (ADP-ribose) Polymerase Inhibitor Olaparib in Heavily Pretreated Patient With Ovarian Carcinosarcoma Harboring a Germline RAD51D Mutation
JCO Precis Oncol
.
2018 Nov:2:1-4.
doi: 10.1200/PO.18.00253.
Authors
Elias A Chandran
1
,
Ian Kennedy
1
Affiliation
1
All authors: Waikato District Health Board, Hamilton, New Zealand.
PMID:
35135167
DOI:
10.1200/PO.18.00253
No abstract available